Solventum Corp reported $1.27B in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Align Technology USD 56.75M 67.86M Sep/2025
Baxter International USD -46M 137M Sep/2025
Becton, Dickinson and Co. USD 493M 81M Sep/2025
Cencora USD -339.7M 1.03B Sep/2025
Dexcom USD 179.8M 74.4M Jun/2025
Insulet USD 87.6M 65.1M Sep/2025
Solventum Corp USD 1.27B 1.18B Sep/2025
West Pharmaceutical Services USD 140M 8.2M Sep/2025
Zimmer Biomet Holdings USD 230.9M 78.1M Sep/2025